SilvanaNmiMartinoDOFACOI

PubMed

• 9 citations
  Genomic characterisation of hormone receptor-positive breast cancer arising in very young women.
  S J Luen, G Viale, S Nik-Zainal, P Savas, R Kammler, P Dell'Orto, O Biasi, A Degasperi, L C Brown, I Láng, G MacGrogan, C Tondini, M Bellet, F Villa, A Bernardo, E Cir...> ;Annals of Oncology. 2023 Apr 1
• 28 citations
  Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials.
  Olivia Pagani, Barbara A Walley, Gini F Fleming, Marco Colleoni, István Láng, Henry L Gomez, Carlo Tondini, Harold J Burstein, Matthew P Goetz, Eva M Ciruelos, Vered S...> ;Journal of Clinical Oncology. 2023 Mar 1
• 13 citations
  Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT.
  Prudence A Francis, Gini F Fleming, István Láng, Eva M Ciruelos, Hervé R Bonnefoi, Meritxell Bellet, Antonio Bernardo, Miguel A Climent, Silvana Martino, Begoña Bermej...> ;Journal of Clinical Oncology. 2023 Mar 1
• 1 citations
  Impact of adjuvant trastuzumab on locoregional failure rates in a randomized clinical trial: North Central Cancer Treatment Group N9831 (alliance) study.
  Carlos Vargas, C.S. Thorpe, Amylou C. Dueck, Kathleen S. Tenner, Nancy E. Davidson, Silvana Martino, Thomas M. Pisansky, E. Shelley Hwang, Michele Y. Halyard, Barbara ...> ;Cancer. 2020 Dec 15
• 3 citations
  Germline Genetic Variants in GATA3 and Breast Cancer Treatment Outcomes in SWOG S8897 Trial and the Pathways Study.
  Victoria L. Larsen, William E. Barlow, Jun J. Yang, Qianqian Zhu, Song Liu, Marilyn L. Kwan, Isaac J. Ergas, Janise M. Roh, Laura F. Hutchins, Susan Kadlubar, Kathy S....> ;Clinical Breast Cancer. 2019 Aug 1
• 55 citations
  Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230.
  Halle C. F. Moore, Joseph M. Unger, Kelly-Anne Phillips, Frances M. Boyle, Erika Hitre, Anna Moseley, David Porter, Prudence A. Francis, Lori J. Goldstein, Henry L. Go...> ;Journal of the National Cancer Institute. 2019 Feb 1
• 343 citations
  Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.
  Prudence A. Francis, Olivia Pagani, Gini F. Fleming, Barbara Walley, M.A. Colleoni, István Láng, Henry L. Gomez, Carlo Tondini, Eva Ciruelos, Harold J. Burstein, H. Bo...> ;The New England Journal of Medicine. 2018 Jun 4
• 68 citations
  PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance).
  Minetta C. Liu, Brandelyn N. Pitcher, Elaine R. Mardis, Sherri R. Davies, Paula N Friedman, Jacqueline E. Snider, Tammi L. Vickery, Jerry P. Reed, Katherine DeSchryver...> ;NPJ Breast Cancer. 2016 Jan 6
• 41 citations
  Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance)
  Jennifer A. Ligibel, Constance Cirrincione, Minetta C. Liu, Marc L. Citron, James N. Ingle, William J. Gradishar, Silvana Martino, William Sikov, Richard Alan Michaels...> ;Journal of the National Cancer Institute. 2015 Sep 1
• 54 citations
  Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole
  Paul E. Goss, JN Ingle, Silvana Martino, Nicholas J. Robert, Hyman B. Muss, Robert B. Livingston, Nancy E. Davidson, E. A. Perez, Yanin Chavarri-Guerra, David Cameron,...> ;Annals of Oncology. 2013 Feb 1
• 164 citations
  Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised cont...
  Kathy S. Albain, William E. Barlow, Peter M. Ravdin, William B. Farrar, Gary V. Burton, Steven J. Ketchel, Charles D. Cobau, Ellis G. Levine, James N. Ingle, Kathleen ...> ;Lancet. 2009 Dec 19
• 255 citations
  Prognostic Utility of the 21-Gene Assay in Hormone Receptor-Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features
  Lori J. Goldstein, Robert Gray, Sunil Badve, Barrett H. Childs, Carl Yoshizawa, Steve Rowley, Steven Shak, Frederick L. Baehner, Peter M. Ravdin, Nancy E. Davidson, Ge...> ;Journal of Clinical Oncology. 2008 Sep 1
• 90 citations
  Concurrent doxorubicin plus docetaxel is not more effective than concurrent doxorubicin plus cyclophosphamide in operable breast cancer with 0 to 3 positive axillary n...
  Lori J. Goldstein, Anne O'Neill, Joseph A. Sparano, Edith A. Perez, Lawrence N. Shulman, Silvana Martino, Nancy E. Davidson> ;Journal of Clinical Oncology. 2008 Sep 1
• 176 citations
  Estrogen- and Progesterone-Receptor Status in ECOG 2197: Comparison of Immunohistochemistry by Local and Central Laboratories and Quantitative Reverse Transcription Po...
  Sunil Badve, Frederick L. Baehner, Robert Gray, Barrett H. Childs, Tara Maddala, Mei Lan Liu, Steve Rowley, Steven Shak, Edith D. Perez, Lawrence J. Shulman, Silvana M...> ;Journal of Clinical Oncology. 2008 May 20
• 49 citations
  Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17
  James N. Ingle, Dongsheng Tu, Joseph L. Pater, Hyman B. Muss, Silvana Martino, Nicholas J. Robert, Martine Piccart, Monica Castiglione, Lois E. Shepherd, Kathleen I. P...> ;Annals of Oncology. 2008 May 1
• 104 citations
  Efficacy, Toxicity, and Quality of Life in Older Women With Early-Stage Breast Cancer Treated With Letrozole or Placebo After 5 Years of Tamoxifen: NCIC CTG Intergroup...
  Hyman B. Muss, Dongsheng Tu, James N. Ingle, Silvana Martino, Nicholas J. Robert, Joseph L. Pater, Timothy J. Whelan, Michael Palmer, Martine Piccart, Lois E. Shepherd...> ;Journal of Clinical Oncology. 2008 Apr 20
• 393 citations
  Cardiac Safety Analysis of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With or Without Trastuzumab in the North Central Cancer Treatment Group N9831 Adjuva...
  Edith A. Perez, Vera J. Suman, Nancy E. Davidson, George W. Sledge, Peter A. Kaufman, Clifford A. Hudis, Silvana Martino, Julie Gralow, S. R. Dakhil, James N. Ingle, E...> ;Journal of Clinical Oncology. 2008 Mar 10
• 45 citations
  Intensive Dose-Dense Compared With High-Dose Adjuvant Chemotherapy for High-Risk Operable Breast Cancer: Southwest Oncology Group/Intergroup Study 9623
  Halle C. F. Moore, Stephanie J. Green, Julie Gralow, Scott I. Bearman, Danika Lew, William E. Barlow, Clifford A. Hudis, Antonio C. Wolff, James N. Ingle, Helen K. Che...> ;Journal of Clinical Oncology. 2007 May 1
• 34 citations
  Sequenced Compared With Simultaneous Anthracycline and Cyclophosphamide in High-Risk Stage I and II Breast Cancer: Final Analysis From INT-0137 (S9313)
  Hannah M. Linden, Charles M. Haskell, Stephanie Green, C. Kent Osborne, George W. Sledge, Charles L. Shapiro, James N. Ingle, Danika Lew, Laura F. Hutchins, Robert B. ...> ;Journal of Clinical Oncology. 2007 Feb 9
• 226 citations
  Effect of Letrozole Versus Placebo on Bone Mineral Density in Women With Primary Breast Cancer Completing 5 or More Years of Adjuvant Tamoxifen: A Companion Study to N...
  Edith A. Perez, Robert G. Josse, Kathleen I. Pritchard, James N. Ingle, Silvana Martino, B. Findlay, Tamara N. Shenkier, Richard Tozer, Michael J. Palmer, Lois E. Shep...> ;Journal of Clinical Oncology. 2006 Aug 1
• 82 citations
  Impact of the Year 2000 Medicare Policy Change on Older Patient Enrollment to Cancer Clinical Trials
  Joseph M. Unger, Charles A. Coltman, John Crowley, Laura F. Hutchins, Silvana Martino, Robert B. Livingston, John S. Macdonald, Charles D. Blanke, D. R. Gandara, E. Da...> ;Journal of Clinical Oncology. 2006 Jan 1
• 190 citations
  Assessment of Quality of Life in MA.17: A Randomized, Placebo-Controlled Trial of Letrozole After 5 Years of Tamoxifen in Postmenopausal Women
  Timothy J. Whelan, Paul E. Goss, James N. Ingle, Joseph L. Pater, Dongsheng Tu, Kathleen I. Pritchard, Shifang Liu, Lois E. Shepherd, Michael Palmer, Nicholas J. Rober...> ;Journal of Clinical Oncology. 2005 Oct 1
• 171 citations
  Chemoendocrine Therapy for Premenopausal Women With Axillary Lymph Node–Positive, Steroid Hormone Receptor–Positive Breast Cancer: Results From INT 0101 (E5188)
  Nancy E. Davidson, A. O’Neill, Allen M. Vukov, C. Kent Osborne, Silvana Martino, Douglas R. White, Martin D. Abeloff> ;Journal of Clinical Oncology. 2005 Sep 1
• 86 citations
  Safety assessment of raloxifene over eight years in a clinical trial setting
  Silvana Martino, Damon Disch, Sherie A. Dowsett, Cheryl A. Keech, John L. Mershon> ;Current Medical Research and Opinion. 2005 Aug 19
• 442 citations
  Continuing outcomes relevant to Evista: Breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene
  Silvana Martino, Jane A. Cauley, Elizabeth Barrett-Connor, Trevor J. Powles, John L. Mershon, Damon Disch, Roberta J. Secrest, Steven R. Cummings> ;Journal of the National Cancer Institute. 2004 Dec 1
• Join now to see all